Knowledge-based industry after market liberalisation: the case of the local pharmaceutical industry in Central and Eastern Europe Online publication date: Mon, 02-Jul-2007
by Andrej Bertoncelj, Mateja Dermastia, Dragan Kesic
International Journal of Technology and Globalisation (IJTG), Vol. 3, No. 2/3, 2007
Abstract: Research of the strategic aspects of the generic pharmaceutical industry in Central and Eastern Europe (CEE) suggests that generic pharmaceutical companies have neglected technological innovation capability, market orientation and performance and have underestimated the process of globalisation. This has resulted in deteriorated performance and lost competitiveness. A recommended approach to improve the situation is competence-based development cooperation in the form of horizontal networks of regional technological hubs, within the capabilities and limitations of each country. However, this approach departs from traditional production and R&D capacity building and is beyond the current political and economic considerations of individual companies and governments.
Online publication date: Mon, 02-Jul-2007
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology and Globalisation (IJTG):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email firstname.lastname@example.org